An organization's process for dealing with substance misuse in the workplace is described in a collection of rules called a substance abuse policy. It should be a tailored document that covers problems with abused alcohol, illicit substances, and prescription medicine. You may be required by law to have a drug abuse policy depending on the kind of business you run. Making an established substance abuse policy can assist keep a drug- and alcohol-free workplace, eventually preserving staff safety and improving customer service. Drug misuse policies cover topics including driving under the influence, abusing prescription medications, preventive strategies, and the effects of drugs on certain demographics. The goal of drug abuse policies in the US is to prevent drug misuse and inform the public about the risks associated with drug use and sales. Drug misuse policies cover topics including driving under the influence, abusing prescription medications, preventive strategies, and the effects of drugs on certain demographics. The goal of drug abuse policies is to prevent drug misuse and inform the public about the risks associated with drug use and sales.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States